News
BNR
10.19
+1.90%
0.19
Weekly Report: what happened at BNR last week (0817-0821)?
Weekly Report · 5d ago
Weekly Report: what happened at BNR last week (0810-0814)?
Weekly Report · 08/17 10:09
Weekly Report: what happened at BNR last week (0803-0807)?
Weekly Report · 08/10 10:05
Weekly Report: what happened at BNR last week (0727-0731)?
Weekly Report · 08/03 10:04
Weekly Report: what happened at BNR last week (0720-0724)?
Weekly Report · 07/27 10:08
Weekly Report: what happened at BNR last week (0713-0717)?
Weekly Report · 07/20 10:05
Weekly Report: what happened at BNR last week (0706-0710)?
Weekly Report · 07/13 10:07
Weekly Report: what happened at BNR last week (0629-0703)?
Weekly Report · 07/06 10:10
Major Insider Move Signals Growing Confidence in Burning Rock Biotech
TipRanks · 07/03 02:03
Burning Rock Biotech CEO Yusheng Han purchases 73,141 ADSs for $618,217
TipRanks · 07/02 11:40
Burning Rock Biotech Founding Chairman And CEO Mr. Yusheng Han Buys 73,141 BNR ADSs On Open Market For ~$618.2K
Benzinga · 07/02 11:22
Burning Rock Announces Founder’s Purchase of Its ADSs
Barchart · 07/02 06:19
Weekly Report: what happened at BNR last week (0622-0626)?
Weekly Report · 06/29 10:06
Weekly Report: what happened at BNR last week (0615-0619)?
Weekly Report · 06/22 10:13
Weekly Report: what happened at BNR last week (0608-0612)?
Weekly Report · 06/15 10:14
Earnings Scheduled For June 9, 2026
Benzinga · 06/09 15:15
Burning Rock Biotech Q1 EPS $(0.20), Same YoY, Sales $15.649M Down From $18.340M YoY
Benzinga · 06/09 14:14
Burning Rock Biotech reports Q1 results
Seeking Alpha · 06/09 11:30
Burning Rock Biotech Posts Lower Q1 2026 Revenue as Shift to In-Hospital Testing Weighs on Growth
TipRanks · 06/09 10:28
Burning Rock Reports First Quarter 2026 Financial Results
Barchart · 06/09 05:38
More
Webull provides a variety of real-time BNR stock news. You can receive the latest news about Burning Rock Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About BNR
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.